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Using a model of lethal oral infection withToxoplasma
gondii, we examined the fate of both induced and
natural regulatory T (Treg) cells in the face of strong
inflammatory responses occurring in a tolerogenic-
prone environment. We found that during highly
T helper 1 (Th1) cell-polarized mucosal immune
responses, Treg cell numbers collapsed via multiple
pathways, including blockade of Treg cell induction
and disruption of endogenous Treg cell homeostasis.
In particular, shutdown of interleukin 2 (IL-2) in the
highly Th1 cell-polarized environment triggered by
infection directly contributes to Treg cell incapacity
to suppress effector responses and eventually leads
to immunopathogenesis. Furthermore, we found
that environmental cues provided by both local
dendritic cells and effector T cells can induce the
expression of T-bet transcription factor and IFN-g
by Treg cells. These data reveal a mechanism for
Th1 cell pathogenicity that extends beyond their
proinflammatory program to limit Treg cell survival.
INTRODUCTION
Failure to properly control immune responses in the face of infec-
tions or at sites of high antigenic exposure leads to pathologic
consequences. To preserve tissue integrity, complementary
strategies are in place, including specialized lymphocytes and
antigen-presenting cell populations. Foxp3-expressing regula-
tory T (Treg) cells represent one of the major arms of this regula-
tory network by controlling both innate and adaptive immune
responses (Sakaguchi et al., 2001).
In some microenvironments, such as the gastrointestinal (GI)
tract, in which immune reactivity against intestinal flora or dietary
antigen poses a substantial risk to the host, regulatory elements
are constitutively represented (Izcue et al., 2006). For instance, in772 Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc.addition to various populations of Treg cells, the GI tract is home
to dendritic cells (DCs) displaying regulatory functions via their
capacity to release cytokines or to induce Treg cells (Coombes
and Powrie, 2008). We and others have shown that in the gut
environment, a substantial fraction of naive T cells can also
become Foxp3+ Treg cells after oral exposure to antigen
(Coombes et al., 2007; Mucida et al., 2005; Sun et al., 2007).
This process is associated with the capacity of gut-associated
lymphoid tissue (GALT) antigen presenting cells (APC) to
generate Treg cells via a mechanism that, in addition to TGF-b,
is dependent on the Vitamin A metabolite retinoic acid (RA)
(Coombes et al., 2007; Denning et al., 2007; Sun et al., 2007).
Nevertheless, even in highly regulated sites, immune
responses need to occur to allow proper control of microbial
expansion. This implies that regulatory mechanisms have to be
temporally neutralized or overcome. Several lines of evidence
suggest that Treg cells themselves are subject to regulation.
Such control can be direct, via triggering Toll-like receptor
ligands (Wei et al., 2009), or indirect, via enhanced activation of
APC or effector T cells (Pasare and Medzhitov, 2003). Another
means by which Treg cells could be controlled is associated
with a loss of function or enhanced apoptosis (Tang et al.,
2008). Recent evidence also supports the idea that Treg cells
can become unstable after exposure to defined stimulatory
signals or in lymphopenic environments (Degauque et al.,
2008; Duarte et al., 2009; Wei et al., 2009; Xu et al., 2007). In
contrast, excessive limitation of regulatory pathways can have
detrimental consequences. Indeed, any failure to maintain a
tight control of the equilibrium between regulation and immunity
is at the core of pathologic processes from autoimmune disor-
ders to pathogen-driven diseases. However, in most circum-
stances, and in particular during infection, critical environmental
cues limiting the induction and function of Treg cells are poorly
understood.
Treg cells control a large array of immune responses both in
the context of highly polarized settings and in various microenvi-
ronments. This implies that maintenance of peripheral homeo-
stasis also relies on the capacity of these cells to appropriately
adapt to the environment they have to regulate. Recent evidence
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Treg cells is required for proper control of defined environments.
For instance, expression of the transcription factor IRF4 by Treg
cells contributes to their capacity to control Th2 cells responses
(Zheng et al., 2009). In contrast, a recent report demonstrated
that expression of T-bet by Treg cells can favor their homing to
Th1 cell environments and is required for the homeostasis and
function of Treg cells during type 1 inflammation (Koch et al.,
2009). How, in pathogenic situations, expression of these tran-
scription factors could also induce the expression of an effector
program by Treg cells and potentially contribute to pathogenesis
has not been addressed.
One of the first models to reveal the immunologic paradox of
microbial control associated with host death is murine infection
with Toxoplasma gondii (T. gondii) (Gazzinelli et al., 1996). This
parasite manipulates innate cells in a way that induces the devel-
opment of a highly polarized Th1 cell response (Gazzinelli et al.,
1994). In certain strains of mice, oral infection with T. gondii
induces a severe form of intestinal inflammation referred to as
the lethal ileitis model (Liesenfeld, 2002; Liesenfeld et al., 1996;
Mennechet et al., 2002).When insufficiently controlled, this path-
ological process that is CD4+ T cell dependent leads to the death
of the infected host (Liesenfeld, 2002; Mennechet et al., 2002).
Using murine T. gondii infection, we explored the interplay
between Treg and effector T cells in this tolerance-prone envi-
ronment following challenge with a virulent pathogen. In partic-
ular, we addressed the factors controlling the induction of Treg
cells and the fate of endogenous Treg cells in a situation in which
regulation is clearly overwhelmed.
Using this model, we found that cues emerging from tissue
resident DCs and effector T cells control the size of Treg cell pop-
ulations via multiple pathways ranging from blockade of Treg cell
induction to limitation of endogenous Treg cell proliferation. In
particular, shut down of IL-2 by effector T cells played a major
role in the pathogenesis of this infection by limiting bioavailability
of Treg cell survival factors. The strong Th1 environment trig-
gered by T. gondii infection also induced T-bet and IFN-g
expression on Treg cells. Together, our data support the idea
that Th1 cells can subvert regulatory networks and become
pathogenic through not only their capacity to produce inflamma-
tory cytokines, but also their reduced capacity to produce
a major survival factor for Treg cells.
RESULTS
Acute Infection by T. gondii Is Associated with Collapse
of Treg Cell Numbers and Frequencies
In order to evaluate the fate of Foxp3+ Treg cells in highly inflam-
matory settings, C57BL/6mice were infected orally with 40 cysts
of the type II T. gondii strain, ME-49. After oral infection, the
parasite was primarily detected in the small intestine, as well as
in distal tissues (Figure 1A and data not shown). ME-49 in
C57BL/6 mice induced severe small intestine inflammation with
loss of epithelial architecture in the ileum and the jejunum, short-
ened villi, massive influx of inflammatory cells, and scattered
patches of necrosis, particularly in Peyer’s patches (Figure 1B;
Figure S1A available online) (Liesenfeld, 2002; Mennechet
et al., 2002). This infection also induced severe necrosis of theliver, leading to hepatic dysfunction, as indicated by increased
concentrations of serum alanine and aspartate aminotransferase
(Figure 1C). Although mice controlled parasite expansion, they
eventually succumbed to immunopathology (Figures 1A and
1D). At various time points after infection, Treg cell frequencies
and absolute numbers were evaluated in different tissues. Gut
pathology peaked between days 8 and 10 and coincided with
a strong reduction of Foxp3+ Treg cell frequencies both at the
primary site (LP) and systemically (Figures 1E and 1F). Scattered
foci of parasites were present along the small intestine, charac-
terized by a massive influx of CD4+ T cells (Figure 1G). At these
sites, Foxp3+ Treg cells were virtually absent (Figure 1G). Of
note, the absolute numbers of Foxp3+ T cells were also signifi-
cantly reduced compared to naive control mice (Figure 1H). In
contrast, the absolute number of CD4+Foxp3 T cells was sus-
tained in all compartments with the exception of the MLN (data
not shown). Thus, after infection with a lethal dose of T. gondii,
Foxp3+ Treg cell numbers and frequencies were dramatically
reduced at the site of infection and systemically.
Failure to Sustain Treg Cell Conversion after T. gondii
Infection
We and others demonstrated that in the GALT, oral exposure to
antigen can induce conversion of naive T cells into Treg cells
(Coombes et al., 2007; Mucida et al., 2005; Sun et al., 2007).
To evaluate if reduced frequencies of Treg cells during T. gondii
infection could be associated with reduced Treg cell conversion,
we adoptively transferred eGFP, CD45.2+ T cells from OTII 3
Foxp3eGFP mice into CD45.1+ recipients that were infected or
not infected with T. gondii. These recipient mice were then fed
ovalbumin (OVA) antigen dissolved in their drinking water. After
5 days of OVA administration, CD45.2+ OVA-specific T cells
had expanded and were readily detectable in the GALT, spleen,
and in distal lymph nodes (LNs) of both infected and noninfected
hosts (Figure 2A and data not shown). Although the frequency of
transferred cells was lower in infected hosts, OVA-specific cells
proliferated robustly in these animals (data not shown and
Figure 2B). Thus, antigen presentation was not impaired during
T. gondii infection. As we previously described in naive control
mice (Sun et al., 2007), Foxp3+ OVA-specific T cells were only
appreciably detected in the GALT, including the LP of naive
hosts (Figure 2C). In contrast, after infection with T. gondii, the
frequency of cells expressing Foxp3 de novo was dramatically
reduced. Rather, transferred CD45.2+ cells efficiently polarized
toward a Th1 cell phenotype after oral feeding with OVA in the
presence of T. gondii (Figure 2D).
Previous studies have demonstrated that inflammatory medi-
ators such as IFN-g can limit the conversion of naive CD4+ T cells
into Foxp3+ T cells (Wei et al., 2007). Indeed, via their capacity to
induce IFN-g production by T cells, LpDCs purified from day-6-
infected mice were significantly less efficient at inducing Foxp3+
T cells compared to LpDCs from naive mice (Figure S2). Similar
data were obtainedwhen naive LpDCs exposed to STAg (soluble
toxoplasma antigen) were utilized in a Treg cell conversion assay
(Figure S2). Collectively, these data demonstrate that T. gondii
establishes an environment that is unfavorable for the constitu-
tive generation of Treg cells in the GI tract via manipulation of
the APC status of activation and induction of effector responses.Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc. 773
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Treg Collapse during InfectionFigure 1. Treg Cell Number Decreases During Acute Toxoplasmosis
C57/BL6 mice were infected orally with 40 cysts of ME-49.
(A) Shows parasite burden in Lamina propria (LP) of small intestine at days 4, 6, 8, and 10 after infection.
(B) Histological assessment of ileum from naive or day 10 postinfection (hematoxylin and eosin stain; magnification 3200).
(C) Amounts of hepatic Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) were assessed in sera from naive or day 9 infected mice.
(D) Survival curve of infected mice (n = 6).
(E) Comparative assessment of CD4+Foxp3+ Treg cell frequencies in LP compartments in naive or day 10 infected mice. Cells were stained for TCRb, CD4, and
Foxp3, and TCR-b+CD4+-gated cells were analyzed for expression of Foxp3 by flow cytometry. Numbers in quadrants refer to the percentage of CD4+ T cells
expressing Foxp3.
(F) Percentages of TCR-b+CD4+ cells expressing Foxp3 between days 0 and 10 after infection in spleen, MLN, and LP compartments.774 Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc.
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Treg Collapse during InfectionReduced Proliferation by Foxp3+ Treg Cells Parallels
Reduced IL-2 Production by Effector T Cells
Limitation of peripheral conversion cannot solely explain the
systemic reduction of Treg cells. One additional explanation
could be associated with reduced proliferation or enhanced
cell death of Treg compared to effector T cells. To evaluate the
proliferative capacity of both populations after infection,
Foxp3+ T cells and Foxp3T cells were stained for Ki-67, a
cellular marker for proliferation. At day 10 postinfection, the
proliferative index of Foxp3+ Treg cells was significantly reduced
compared to that of Foxp3 T cells (Figure 3A). Similar data were
obtainedwhen both subsets of cells were gated on CD62L nega-
tive population (Figure S3A). We also assessed the expression of
the antiapoptotic molecule Bcl-2 on both Foxp3 and Foxp3+
cells and found that both populations downregulate Bcl-2 with
the same kinetics (Figure S3B). In addition, both effector and
Treg cells expressed higher amount of the apoptotic markers an-
nexin V and caspase 3 in infected mice when compared to naive
mice (data not shown). Thus, these findings indicate that Treg
cell renewal is impaired during T. gondii infection via deprivation
of essential survival factors.
Previous studies have demonstrated that the cytokine IL-2
plays a dominant role in promoting the expansion and survival
of Treg cells (Malek and Bayer, 2004). At steady-state condi-
tions, a large fraction of CD4+ T cells from the small intestine
lamina propria retained the potential to produce IL-2 (Figure 3B).
However, during the course of the infection, the capacity of CD4+
T cells to produce IL-2 was dramatically reduced (29% with an
MFI of 69.9 ± 1.2 for naive mice versus 4% with an MFI of 12.3 ±
0.63at10dayspostinfection) and replacedby theability tosecrete
the effector cytokine IFN-g. At the tissue level, IL-2 mRNA was
also significantly reduced in the LP and spleen (Figure 3C). To
assess IL-2 protein release, splenocytes of naive or infected
mice were restimulated for 12 hr with anti-CD3. Consistent with
data shown in Figures 3B and 3C, IL-2 release was significantly
reduced in infected mice compared to naive mice (Figure 3D).
This reduced capacity to produce IL-2 paralleled Treg cell
contraction (Figure 3E), supporting the idea that in the face of
a strong Th1 cell response, limiting bioavailability of this cytokine
may contribute to the reduction of Treg cells in the infected host.
Acquisition of Effector Phenotype by Treg Cells
during T. gondii Infection
IL-10 was previously shown to play a dominant role in the control
of gut inflammation and to limit immunopathological processes
induced by T. gondii infection (Gazzinelli et al., 1996; Suzuki
et al., 2000; Wilson et al., 2005). We therefore assessed whether
the remaining Treg cells during the inflammatory process had an
altered capacity to produce IL-10. As previously shown, under
steady-state conditions, a substantial proportion of LP Treg cells
can produce IL-10 in theGI tract (Uhlig et al., 2006) (Figure 4A). At
day 9 after infection, a sizable fraction of Foxp3 T cells acquired
Figure 2. Failure to Sustain Treg Cell
Conversion after T. gondii Infection
CD45.1+ mice were orally infected or not with
ME-49. Four days after infection, recipient mice
received CFSE-labeled CD45.2+eGFPOT-II
T cells (1.5 3 106) and were fed with OVA antigen
in drinking water for 5 days. On day 9 after infec-
tion, TCR-b+CD4+CD45.2+-gated T cells were
assessed for intracellular Foxp3 expression and
CFSE dilution.
(A) Detection of Foxp3+ cells is illustrated for small
intestinal LP in naive or day 9 infected mice.
(B) Proliferation of transferred cells from the LP
was assessed by CFSE dilution.
(C) Percentage of CD45.2+eGFPOT-II T cells
expressing Foxp3 in LP or MLN from naive (open
circle) or day 9 (closed circle) infected mice.
Each dot represents an individual mouse (n = 3).
(D) LP cells were briefly restimulated with PMA
and ionomycin and stained for TCR-b, CD4,
CD45.2, T-bet, and IFN-g. Histograms summarize
the percentage of TCR-b+CD4+CD45.2+ cells
expressing T-bet and IFN-g. Error bars represent
the SDs of the means of three individual mice.
The experiment shown was performed three
times with similar results (*p < 0.05; **p < 0.01;
***p < 0.001).
(G) Foxp3eGFP mice were infected with 40 cysts of ME-49 expressing RFP. Day 10 after infection, small intestine sections were stained for CD4, and infected sites
were analyzed by confocal microscopy (CD4, purple; Foxp3eGFP, green; T. gondii, red).
(H) Absolute numbers of TCR-b+CD4+Foxp3+ cells in various tissues between day 0 and 12 postinfection. Histograms represent the mean number of Treg cells
(n = 3) ± SD. All experiments shown were performed at least three times with similar results. Error bars represent the SD of the means of 3 individual mice. Statis-
tical comparisons were performed using the Student’s t test (*p < 0.05; **p < 0.01; ***p < 0.001).Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc. 775
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previous observations showing that cells with this phenotype
are induced during T. gondii infection (Jankovic et al., 2007). At
this time point, IL-10 production by Treg cells in the small intes-
tine increased and was acquired in the spleen (Figure 4A). Thus,
although the number of Treg cells was dramatically reduced after
T. gondii infection, their capacity to produced IL-10 was not
impaired.
Figure 3. Reduced Treg Cell Proliferation Parallels Reduced IL-2 Production by Effector T Cells during Acute Infection by T. gondii
Micewere inoculated orally with 40 cysts ofME-49. Spleen andMLNcells were isolated fromnaive or infectedmice and stained for TCR-b, CD4, Foxp3, andKi-67.
(A) Comparative analysis of Ki-67 expression in CD4+TCR-b+Foxp3 (open circle) or CD4+TCR-b+Foxp3+ (closed circle) cells during infection by flow cytometry.
The experiment shown was performed two times with similar results (n = 3).
(B) At days 0, 4, 6, 8, 10 after infection, LPcellswere shortly restimulated in vitrowithPMAand ionomycin in thepresence ofBrefeldin A and stained for TCR-b, CD4,
Foxp3, IL-2, and IFN-g. Dot plots illustrate IL-2 and IFN-g staining profiles of TCR-b+CD4+Foxp3 cells.
(C) At day 9 after infection, mRNA was extracted from splenic or LP cells, and quantitative RT-PCR of IL-2 mRNA was performed. Histograms show the means of
3 individuals mice ± SDs (AU, arbitrary unit).
(D) Spleen cellswere extracted fromnaive, day 6, or day 10 infectedmice, stimulatedwitha-CD3, and IL-2 secretionwasevaluated byELISA12hr after stimulation.
(E) Histograms and dot plots represent IL-2 production by CD4+Foxp3 and Treg cell frequencies between days 0, 4, 6, 8, and 10 after infection in LP
compartments.
Experiments shown in (B), (C), and (D) were performed three times with similar results (n = 3; *p < 0.05; **p < 0.01; ***p < 0.001).776 Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc.
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acquired the capacity to express the effector cytokine IFN-g,
albeit to a lower level than effector T cells (Figure 4A). After expo-
sure of purified CD4+ T cells to DCs loaded with STAg, more than
80% of Foxp3+ T cells produced IFN-g (Figure 4B). The expres-
sion of this cytokine paralleled that of effector T cells, with the
Figure 4. Acquisition of Effector Phenotype by Treg Cells during T. gondii Infection
CD4+TCR-b+ cells from the spleen, MLN, LP, and IEL compartments were analyzed for expression of Foxp3, IL-10, and IFN-g by flow cytometry 8 days after oral
infection with 40 ME-49 cysts.
(A) Dot plots illustrate IL-10 and IFN-g intracellular staining profiles of Foxp3 or Foxp3+ cells from naive or day 8 infected spleen and LP compartments. Numbers
in quadrants refer to the percentage of each subset.
(B) CD4+TCRb+ cells from naive or day 9 infected LP compartment were incubated with splenic DC in presence of STAg for 15 hr and Brefeldin A . Dot plots
illustrate Foxp3 and IFN-g intracellular staining profiles of TCR-b+CD4+ gated cells.
(C) Percentages of Foxp3 or Foxp3+ CD4+TCR-b+ cells producing IFN-g during the infection in spleen, MLN, LP, and IEL compartments (cells were restimulated
as in [A]).
(D) T-bet and IFN-g expression were analyzed by flow cytometry in naive or day 8 infected MLN compartment on CD4+TCR-b+Foxp3 and CD4+TCR-b+Foxp3+
cells.
(E) CD45.2+CD4+eGFP T cells (2 3 106) isolated from Foxp3eGFP mice were transferred into CD45.1+ recipient mice. At day 8 after infection, CD4+TCR-
b+CD45.1+ or CD45.2+ cells from the spleen were analyzed by flow cytometry for Foxp3 and IFN-g expression. The results shown are representative of three
independent experiments. Each dot plot represents one mouse, and error bars represent the SD of the means of three individual mice.Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc. 777
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(Figure 4C). A recent report showed that Treg cells can express
T-bet during Th1 settings (Koch et al., 2009). To address if T-bet
could control IFN-g production by Foxp3+ cells, we evaluated
the expression of this transcription factor by Foxp3+ cells. We
observed that a high fraction of Treg cells also expressed T-
bet during T. gondii infection with the highest proportion found
in the spleen and LP (Figure S4A). All IFN-g-expressing Foxp3+
T cells also expressed T-bet (Figure 4D). To assess if IFN-g
production by Treg cells was compatible with effector function,
purified Foxp3+ T cells from T. gondii infected mice were incu-
bated with macrophages previously infected with T. gondii. In vi-
tro, Foxp3+ T cells from infectedmice displayed effector function
based on their capacity to limit parasite expansion and induce
NO by infected macrophages (Figure S5). We next evaluated if
this phenotype could interfere with their suppressive capacity.
We found that, in vitro, Treg cells from infectedmice were as effi-
cient as Treg cells from naive mice to suppress proliferation of
responder T cells from infected mice (Figure S4B). In these
suppression assays, the production of IFN-g by effector T cells
was reduced although not fully suppressed in the presence of
Treg cells from infected mice (Figure S4C).
Although we had previously shown that Treg cell conversion
was impaired in the context of T. gondii infection (Figure 2), we
still needed to address the possibility that Foxp3+ cells
producing IFN-g could arise from effector T cells. To this end,
we transferred highly purified Foxp3 T cells into infected recip-
ient mice expressing the congenic marker CD45.1. At day 8 after
transfer, transferred cells expressing CD45.2 expressed compa-
rable amount of IFN-g to their endogenous counterpart but did
not acquire Foxp3 (Figure 4E). Conversely, when highly purified
Treg cells were transferred into congenic recipients, these cells
acquired the capacity to express T-bet and IFN-g (data not
shown). Together, these data reveal that during T. gondii infec-
tion, Foxp3+ Treg cells acquire Th1 cells properties, namely
expression of T-bet and IFN-g.
DCs from Infected Mice Induce T-bet Expression
and IFN-g Production by Treg Cells
We next assessed the cues that induce T-bet and IFN-g expres-
sion by Foxp3+ Treg cells. LpDCs purified from either naive or
infected mice were incubated with highly purified Foxp3+
T cells from peripheral lymphoid organs, and expression of
T-bet was evaluated after TCR stimulation. Previous reports
demonstrated that T. gondii can induce the production of a large
array of inflammatory cytokines by splenic DCs (Gazzinelli et al.,
1994; Reis e Sousa et al., 1999; Sher et al., 1998). Similarly, we
found that in contrast to LpDCs purified from naive mice, LpDCs
purified from infected mice expressed high amount of message
for p35 and p28, subunits of the IL-12 and IL-27 cytokines,
respectively (Figure S6). Previous reports have suggested that
induced Treg cells may be less stable than naturally occurring
Treg cells (Floess et al., 2007). To obtain a pure population of
natural Treg cells and to minimize contamination by peripherally
induced Treg cells, Foxp3+ T cells were purified from the thymus,
and expression of T-bet was compared to Treg cells from the
spleen and MLN. After 5 days in culture, a small fraction of
Foxp3+ Treg acquired T-bet expression when exposed to LpDCs
from naive mice (Figure 5A). In contrast, after exposure of Treg778 Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc.cells to LpDCs from infected mice, a substantial fraction of
Treg cells had acquired T-bet expression regardless of their
origin (Figure 5A). Acquisition of T-bet by Treg cells was partially
blocked by incubation with a-IFN-g and a-IL-12 antibodies
(Figure 5A).
After incubation with LpDCs from infected mice, only a small
fraction of Treg cells produced IFN-g, and addition of exogenous
IL-12 was required to induce substantial amounts of IFN-g,
suggesting that Treg cells have acquired the capacity to
respond to IL-12 (Figure 5B). Indeed, exposure of Treg cells
from T. gondii infected mice to IL-12 induced significantly
more Stat4 phosphorylation, a hallmark of IL-12 signaling
(Jacobson et al., 1996), compared to Treg cells from naive
mice (Figure 5C). IFN-g production by Treg cells was strictly
dependent on T-bet expression because Tbx21/ Treg cells
fail to produce this cytokine even in the presence of high amount
of IL-12 (Figure 5B).
Although Treg cell conversion was strongly inhibited during
T. gondii infection, we wanted to evaluate if the induction of
a Th1 cell phenotype could also be observed on induced Treg
cells. LpDCs from infected mice were less efficient at inducing
Foxp3 expression in vitro when compared to LpDCs from naive
mice (Figure S2). However, unlike LpDCs from naive mice,
LpDCs from infected mice promoted T-bet expression by
Foxp3+ Treg cells (Figure 5D). Neutralizing IFN-g abolished
T-bet expression, whereas blocking IL-12 only had a partial
effect, suggesting that T-bet expression is more dependent on
IFN-g than IL-12 signaling (Figure 5D). In contrast, addition of
IL-12 dramatically enhanced expression of IFN-g by Treg cells
in the presence of LpDCs from naive or infected mice, whereas
IFN-g had only a modest effect (Figure 5E).
Thus, for both naturally occurring and induced Treg cells,
T-bet is readily induced by LpDCs from infected mice. In both
cases, expression is dependent on IFN-g, but acquisition of
IFN-g by Treg cells is only observed in the presence of high
amounts of IL-12.
Enhancement of Treg Cell Survival and Stability Protects
Mice from Pathology
Recent studies have shown that coadministration of IL-2 and
a-IL-2 antibody in the form of a complex increases the biological
activity of this cytokine. Some of these complexes can specifi-
cally amplify Treg cell populations in vivo (Boyman et al.,
2006). We utilized this approach to evaluate how IL-2 availability
could contribute to Treg cell contraction and T. gondii pathogen-
esis. Mice infected with T. gondiiwere treated with IL-2-anti-IL-2
complexes, and immune responses and pathology were evalu-
ated at day 9 after infection. Strikingly, treatment with IL-2
complexes limited the crash of Treg cells in all tissues
(Figure 6A). Such treatment also significantly increased the
expression of the anti-apototic Bcl-2 molecule in these cells
(Figure 6B). Enhanced Treg cell frequency and survival was
associated with reduced T-bet and IFN-g expression by Treg
cells in all compartments analyzed (Figures 6C and 6D). To
confirm that IL-2 treatment acted on the endogenous Treg cell
compartment, highly purified Treg cells were transferred into
congenic hosts that were infected with T. gondii and treated
with IL-2 complexes. Treatment with IL-2 complexes prevented
the expression of IFN-g by transferred Treg cells (Figure S7A).
Immunity
Treg Collapse during InfectionFigure 5. DCs from Infected Mice Imprint T-bet Expression and IFN-g Production on Both Endogenous and Induced Treg Cells
(A) CD4+eGFP+ cells isolated fromperipheral lymphoid tissue (spleen,MLN) or the thymus of Foxp3eGFPmicewere cultivatedwith purified LpDC from naive or day
6 infectedmice in the presence of IL-2 and a-CD3. Isotype controls or aIL-12p40 and aIFN-gwere added at the beginning of cocultures of peripheral Treg cell and
LpDCs. After 5 days of culture, cells were stained for TCR-b, CD4, Foxp3, and T-bet and analyzed by flow cytometry. Histogram represents the mean of triplicate
wells ± SD.
(B) Spleen andMLNCD4+CD45RBloCD25hi cells isolated fromWT or Tbx21/mice were cultivated with purified LpDCs from day 6 infectedmice in the presence
of IL-2 and a-CD3, with or without addition of IL-12. After 5 days of culture, cells were shortly restimulated in vitro by PMA and ionomycin in the presence of
Brefeldin A and stained for TCR-b, CD4, and Foxp3. Dot plots are representative of staining for T-bet and IFN-g on TCR-b+CD4+Foxp3+ cells. Experiments shown
in (A) and (B) were performed three times with similar results.
(C) At day 8 after oral infection with 40 ME-49 cysts, MLN cells were briefly restimulated in vitro with IL-12; stained for TCR-b, CD4, Foxp3, and pSTAT-4; and
analyzed by flow cytometry. Graphs show the percentage of TCR-b+CD4+Foxp3+ expressing pSTAT-4 from naive (open circle) or day 8 infected (closed circle).
Each dot represents one mouse.
(D) and (E) CD4+CD25CD44loFoxp3 T cells isolated from Foxp3eGFPwere culturedwith exogenous TGF-b and a-CD3 in presence of LpDCpurified from naive or
day 6 infected mice with indicated blockingmAb (aIL-12p40, aIFN-g) or isotype control or with indicated cytokines (IL-12p70, IFN-g). After 5 days of culture, cells
were shortly restimulated in vitro and T-bet (D) or IFN-g (E) expression was analyzed on TCR-b+CD4+Foxp3+ cells by flow cytometry. Histograms show summary
of results obtained for triplicate wells ± SD. Experiments shown in (C), (D), and (E) were performed two times with similar results (*p < 0.05; **p < 0.01; ***p < 0.001).Enhanced Treg cell frequencies were also associated with
reduced effector responses in most compartments (data not
shown) and as a consequence, enhanced brain cyst numbers
(Figure 6E). Importantly, infected mice treated with IL-2-anti-
IL-2 complexes exhibited significantly reduced morbidity com-
pared to control mice with reduced inflammation of the small
intestine (Figure S7B) and reduced necrosis of the liver with
restoration of liver enzymes to control levels (Figures 6F and 6G).
To further probe the potential link between IL-2 starvation and
the acquisition of an effector phenotype by Treg cells, we evalu-
ated the phenotype of Treg cells in the complete absence of IL-2.
In the absence of infection, mice deficient in IL-2 spontaneouslydevelop an autoimmune inflammatory disease associated with
a dramatic reduction in peripheral Treg cell frequencies (Fig-
ure 6H) (Kramer et al., 1995). Foxp3+ Treg cells purified from
il2/ mice sustained suppressive function in vitro (data not
shown). Concomitant with development of the inflammatory
disease and in contrast with il-2+/ littermate controls, Foxp3+
T cells from il-2/ mice expressed high amount of T-bet in
all the tissues analyzed (Figure 6I and data not shown). Further-
more, a significant proportion of Treg cells expressed IFN-g in
tissues undergoing severe inflammation, such as the colon and
the spleen (Figure 6I and data not shown). Thus, the develop-
ment of inflammatory disease in IL-2-deficient mice is not onlyImmunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc. 779
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Treg Collapse during InfectionFigure 6. Enhancement of Treg Cell Survival and Stability Protects Mice from Lethal Outcome
Mice inoculated orally with 40 ME-49 cysts were treated with IL-2-anti-IL-2 complexes or not for 5 consecutive days. At day 9 after infection, TCR-b+CD4+cells
were analyzed for expression of Foxp3, Bcl2 and T-bet by flow cytometry.
(A) Treg cell percentages in spleen and LP compartments from naive (gray circle), infected and untreated (closed circle), or infected and treated (open circle) mice.
Each dot represents an individual mouse.
(B) Percentages of Treg cell expressing Bcl-2 in spleen or MLN compartments.
(C) Representative staining for Foxp3 and T-bet expression by TCR-b+CD4+ gated LP cells.
(D) Histograms summarize the percentage of TCR-b+CD4+Foxp3+ cells producing IFN-g in the spleen and LP compartments from day 9 infected mice treated or
not with IL-2-anti IL-2 complexes. Error bars represent the SD of the means of three individual mice.
(E) Mice were inoculated orally with 5 ME-49 cysts, and the number of cysts was counted in the brain at 40 days after infection. Each dot represents an individual
mouse (n = 5).
(F) The amount of hepatic Alanine Aminotransferase (ALT) was assessed in the serum at day 9 after infection. Error bars represent the SDs of the means of
four individual mice.780 Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc.
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Treg Collapse during Infectionassociated with reduced Treg cell frequencies but also can be
correlated to the acquisition of a Th1 cell phenotype by Treg
cells. Altogether, these results support the concept that in T.
gondii infection, IL-2 withdrawal during the Th1 cell response
contributes to Treg cell collapse and directly or indirectly to the
acquisition of a Th1 cell phenotype by Treg cells.
Treg Cell Number Collapse Correlates with Parasite
Pathogenesis
We postulated that Treg cell number collapse and acquisition of
effector phenotype during T. gondii infection should correlate
with pathogenicity. The capacity of T. gondii to cause disease
can be associated with the strain of mice, the dose of parasite,
or the type or clone of parasite used. When C57BL/6 mice
were infected with a lower dose of parasite that allows host
survival and only induces marginal pathology (Figure 7A), Treg
cells were maintained at a higher frequency than in the lethal
dose (Figure 7B). We next infected mice with clones derived
from ME-49 that display distinct virulence. At 40 cysts, clone
C1 induced high amount of gut and systemic pathology, leading
to the death of the infected host (Figure 7C and data not shown).
In contrast, clone F1 induced onlymarginal pathology and allows
for host survival at the same dose.
As previously shown for ME-49, clone C1 induced Treg cell
number collapse and a dramatic reduction of IL-2 production
by effector T cells in the GALT and systemically (Figure 7D and
data not shown). Furthermore, after C1 infection, a substantial
fraction of Treg cells expressed IFN-g. In contrast, after infection
with clone F1, Treg cell populations were maintained, and this
correlated with sustained production of IL-2 by effector T cells
(Figure 7D). In addition, Treg cells expressed only marginal
amounts of IFN-g, compared to infection with the more virulent
C1 clone (7% of Treg cells versus 42% with C1 infection,
Figure 7D). Similar data were obtained under conditions associ-
ated with lower level of pathogenicity, such as in BALB/c mice
(Figure S8). Thus, our data suggest that Treg cell number
collapse and acquisition of IFN-g only occur in highly pathogenic
situations.
DISCUSSION
Here, we showed that a highly Th1 cell type-polarized mucosal
immune response can induce the breakdown of the Treg cell
population. Such a decline occurred via multiple mechanisms,
including blockade of Treg cell induction and a dramatic reduc-
tion of the endogenous Treg cell population. In particular, our
data suggest that shutdown of IL-2 in highly Th1 cell type-
polarized environment contributes to the incapacity of Treg cells
to parallel effector responses and consequently leads to immu-
nopathogenesis. In addition, we found that environmental
cues provided by both local DCs and effector T cells can confer
T-bet expression in Treg cells, which leads to IFN-g production
by these cells. Thus, this study provides an evaluation of mech-anisms that negatively control Treg cells during an infectious
disease and demonstrates its importance in pathogenicity.
During T. gondii infection, protective lymphocytes concomi-
tantly drive the immunopathologic process (Liesenfeld et al.,
1996). In a nonlethal model of T. gondii after intraperitoneal infec-
tion, IL-27, as well as IL-10-producing Th1 cells, limits excessive
effector responses (Gazzinelli et al., 1996; Jankovic et al., 2007;
Villarino et al., 2003). Given Treg cells’ ability to dampen exces-
sive effector responses, these cells should also limit responses
to this pathogen and preserve tissue integrity. Indeed, selective
depletion of Foxp3+ cells using mice expressing a diphtheria
toxin (DT) receptor under the control of the foxp3 gene locus
(Lahl et al., 2007) further enhanced effector T cell responses
during nonlethal T. gondii infection (data not shown). Conversely,
preventing this numerical collapse through treatment by
increasing the amount of IL-2 resulted in marked reductions of
both morbidity and immunopathology. Altogether, our results
support the idea that Treg cells play a major role in preservation
of host tissue integrity during T. gondii infection.
We and others have shown that the gut-associated lymphoid
tissue is a preferential site for driving peripheral induction of
Foxp3+ Treg cells (Coombes et al., 2007; Mucida et al., 2005;
Mucida et al., 2007; Sun et al., 2007). Our data demonstrate
that this process is dramatically inhibited during T. gondii
infection. Several reports suggest that presence of Th1 effector
cytokines or high level of costimulation—both events that char-
acterize T. gondii infection (Gaddi and Yap, 2007)—had an
antagonistic effect on Treg cell conversion (Benson et al.,
2007; Bettelli et al., 2006; Kretschmer et al., 2005; O’Malley
et al., 2009; Veldhoen et al., 2006; Wang et al., 2008; Wei
et al., 2007). We recently showed that gut DCs no longer induce
Treg cells when stimulated with bacterial DNA (Hall et al., 2008).
Similarly, gut DCs exposed to Toxoplasma antigen are impaired
in their capacity to induce Treg cells. Thus, tolerogenic DCs lose
their capacity to induce Treg cells when activated by defined
commensal products or pathogens in favor of the induction of
effector responses. Upon challenge with T. gondii, gut-resident
APCs are likely to be replaced by inflammatory cells that have
not been conditioned by the gut environment (Dunay et al.,
2008). Previous reports support the idea that restricted or defec-
tive Treg cell conversion can enhance immunopathology in the
gut or lung (Curotto de Lafaille et al., 2008; Izcue et al., 2008).
The relative contribution of impaired Treg cell conversion to the
pathology induced by T. gondii remains difficult to evaluate but
is likely to play a role in the overall decrease of Treg cells during
infection. Our findings also raise the possibility that exposure to
antigen at a time of acute infection may impair the acquisition of
tolerance against innocuous antigens that could, in turn, further
contribute to the pathologic process.
Recent findings suggest that acquisition of transcription
factors in addition to Foxp3 can confer unique functional charac-
teristics to Treg cells (Zheng et al., 2009). For instance, their
expression of T-bet was recently shown to favor their capacity
to control Th1 responses (Koch et al., 2009). In the context of(G) Histological assessment of liver.
(H) Comparative assessment of CD4+Foxp3+ Treg cells in spleen and colon compartments in age-matched Il2+/ or Il2/ naive mice.
(I) Dot plots illustrate the T-bet and IFN-g expression of TCR-b+CD4+ Foxp3+ or Foxp3 cells in the spleen of naive Il2+/ or Il2/ mice. The results shown are
representative of three independent experiments with similar results (*p < 0.05; **p < 0.01; ***p < 0.001).Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc. 781
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Treg Collapse during InfectionFigure 7. Treg Cell Collapse Correlates with Parasite Virulence
(A) Mice were inoculated orally with 10 or 60ME-49 cysts. At day 9 after infection, pathology in the small intestine duodenum (D), jejunum (J), ileum (I), and Peyer’s
patches (PP) were compared (n = 3).
(B) Mice were inoculated orally with 10 or 40 cysts of ME-49. Comparative assessment of CD4+Foxp3+ Treg cells frequencies in MLN and LP compartments in
naive or day 9 infected C57BL/6 mice. Cells were stained for TCR-b, CD4, and Foxp3. TCR-b+CD4+-gated cells were analyzed for Foxp3 expression by flow
cytometry. Each dot represents one mouse (open circle, naive; gray circle, 10 cysts; closed circle, 40 cysts). The results shown are representative of two
(A) or three (B) independent experiments with similar results. Statistical comparisons were performed using the Student’s t test (*p < 0.05; **p < 0.01; ***p < 0.001).
(C) Mice were inoculated orally with 40 cysts of ME-49 clone F1 or clone C1. The survival curves of infected mice were compared (n = 5; ***p < 0.001).
(D) At day 9 after infection, LP cells were analyzed by flow cytometry for TCR-b, CD4, and Foxp3 expression or for TCR-b, CD4, IL-2, IFN-g, and Foxp3 expression
after in vitro restimulation with PMA and ionomycin in the presence of Brefeldin A. Each dot plot represents onemouse among three used per condition. Numbers
in quadrants represent the percentage of each subset. The results shown in (C) and (D) are representative of two independent experiments.T. gondii infection, Treg cells express high levels of the Th1 tran-
scription factor T-bet. When isolated from the primary site of
T. gondii infection, lamina propria DCs can readily induce T-bet
expression by Treg cells via, in part, their capacity to induce
IFN-g by T cells. As LpDCs gain the capacity to produce IL-12
in this environment, we found that T-bet expression was associ-
ated with acquisition of responsiveness to IL-12 via enhanced
Stat4 phosphorylation. Other factors—such as IL-27 that we
found highly expressed in LpDCs from infected mice—are also
likely to contribute to this imprinting. Based on recent findings
that T-bet favors Treg cell tropism to sites of Mycobacterium
tuberculosis infection, we could speculate that under nonlethal
T. gondii infection, T-bet may confer an advantage to Treg cells.
Indeed, we found that expression of T-bet did not interfere with
the capacity of Treg cells to suppress proliferation of effector
T cells in vitro. Furthermore, T-bet expression correlated with
expression of CXCR3 (data not shown).
Our data reveal that in highly virulent settings, Treg cells do not
accumulate preferentially at site of infection. Further, T-bet
expression led to IFN-g production, a cytokine responsible for
both effector and pathogenic responses during T. gondii infec-
tion. Recent evidence shows that lymphocytesmaintain a certain
degreeof plasticitywith respect to their capacity toproducecyto-782 Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc.kines (Lee et al., 2009; Wei et al., 2009). Cells expressing both
Foxp3 and IL-17 can be found in mucosal tissue or in vitro
cultures (Lee et al., 2009; Xu et al., 2007; Yang et al., 2008).
Genome-wide mapping of H3K4me3 and H3K27me3 performed
in Treg cells revealedmarkers of both repression and induction at
the tbx21 locus. On the other hand, Ifng locus did not shown any
sign of induction or repression (Wei et al., 2009), suggesting that
it is poised for transcriptional activation. A previous report
demonstrated that regulatory T cells expressing both Foxp3
and T-bet were capable of controlling airway hyperactivity (Stock
et al., 2004). A role for IFN-g in mediating Treg cell function has
been reported in a model of graft transplants (Sawitzki et al.,
2005), and recent evidence demonstrates that, in vitro, Treg cells
can produce this cytokine (Wei et al., 2009); however, the
capacity of Treg cells to express IFN-g under physiologic
settings, and in particular during infection, remained unclear.
Our data support the idea that such an effect may be associated
with, or arise as a consequence of, pathology. Indeed, we only
detected IFN-g production by Treg cells in situations leading to
death of the infected host. This would suggest that in the pres-
enceof highamount of inflammatorymediators, T-bet expression
may reach a threshold that superimposes an effector programon
Treg cells.
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Treg cells can contribute to tissue damage or lose suppressive
capacity if armed with effector cytokines (Hsieh et al., 2006).
Indeed, a recent report highlighted that Foxp3 instability and
acquisition of IFN-g can favor the development of autoimmune
diabetes (Zhou et al., 2009). However, the fate of bona fide
Treg cells was not evaluated in this study. Here, we demonstrate
that Treg cells from T. gondii-infected mice can produce IFN-g
and exert effector function as illustrated by their capacity to limit
parasite growth. However, based on the small frequency of
remaining Treg cells in this particular setting, the overall contri-
bution of these cells to the pathogenesis of the infection remains
difficult to assess.
Our data compellingly suggest that one trigger of immunopa-
thology during Th1 polarized responses may be the limitation of
IL-2 availability. Over the past few years, a strong body of litera-
ture suggests that a primary function of IL-2 is to promote the
expansion and survival of Treg cells (Malek and Bayer, 2004).
Indeed, previous work showed that the number of Treg cells
can be indexed to the number of IL-2-producing effector cells
(Almeida et al., 2006). Intriguingly, IL-2 production declines
upon differentiation into effector T cells. Accordingly, we found
that following oral infection with T. gondii, the emergence of
a Th1 response was associated with a sytemic reduction of IL-2
production by CD4+ T cells. During T. gondii infection, IL-27
and IL-12 were shown to synergize to limit IL-2 production (Villar-
ino et al., 2007). A link between defective IL-2 production and
Treg cell dysfunction has been previously proposed as one of
themechanisms associated with breakdown of tolerance in non-
obese diabetic mice (Tang et al., 2008). In our study, we found
that following infection, Treg cells expressed lower levels of
Bcl-2 and increased levels of apoptotic markers compared to
Treg cells from naive mice, suggesting that deregulation of Treg
cell frequencies is a consequence of impaired Treg cell turnover.
Because our data support the idea that cytokine reduction
contributes to Treg cell collapse, such effect is likely to occur
regardless of Treg cell specificity. A role for IL-2 is further sup-
ported by our observation that treatment of mice with an IL-2-
anti-IL-2complex (Boymanetal., 2006) can restoreTregcell prolif-
eration, frequencies, and survival following infection. Of note, in
this particular setting, we cannot fully exclude the possibility that
IL-2 directly increases Treg cell expansion (Webster et al., 2009)
rather than restoring IL-2 levels in infected mice. Nevertheless,
the observation that Treg cells from IL-2-deficient mice recapitu-
late the phenotype in T. gondii-infected mice supports the idea
that IL-2 withdrawal plays a major role in the alterations observed
during infection. It is tempting to speculate that under most
circumstances, Treg cells would be the primary bystander targets
of IL-2withdrawalduringaTh1 response, thusprovidinganoppor-
tunity for effector responses to control infection.
Our work offers new insights into microbial pathogenesis
associated with the subversion of regulatory pathways by
effector responses. Our data demonstrating that Treg cell
acquire effector functions are highly relevant in the context of
therapeutic approaches aimed at inducing or transferring Treg
cells during the onset of autoimmune diseases. Furthermore,
understanding how pathogenic microbes manipulate niches to
undermine regulatory responses provides potential therapeutic
strategies to control host homeostasis at large.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (WT) and B6.SJL mice were purchased from Taconic Farms and
Jackson Laboratory or bred in house. Tbx21/ and Il-2/ mice were
purchased from Jackson Laboratory. Foxp3eGFP reporter mice (Foxp3eGFP)
and DEREG mice were obtained from Dr. M. Oukka (Bettelli et al., 2006)
and Dr. T. Sparwasser (Lahl et al., 2007), respectively. We generated
OT-IIxFoxp3eGFP mice. All mice were bred and maintained under pathogen-
free conditions at an American Association for the Accreditation of Laboratory
Animal Care accredited animal facility at the NIAID and housed in accordance
with the procedures outlined in the Guide for the Care and Use of Laboratory
Animals under an animal study proposal approved by the NIAID Animal Care
and Use Committee. Mice between 8 and 12 weeks of age were used. Mice
were gender, vendor, and age matched for each experiment.
Parasite and Infection Protocol
ME-49 type II strain (ATCC no. 50840) (American Type Culture Collection,
Manassas, VA, USA) of T. gondii was used for production of tissue cysts in
C57BL/6 mice. Tissue cysts used in experiments were obtained from mice
that were inoculated 1–3months previously, with five cysts by gavage. Animals
were sacrificed, and the brains were removed and homogenized in 1 ml of
phosphate buffer saline (PBS) (pH 7.2). Tissue cysts were counted on the basis
of 3 or more aliquots of 20 ml. For challenge studies, 8- to 12-week-old mice
were used for all studies. Mice were infected by oral route. Parental ME-49
was electroporated with RFP and selected for red fluorescence. Two clones
(ME-49 C1 and ME-49 F1) were established that possessed different degrees
of virulence when passed through mice. STAg was prepared as previously
described (Grunvald et al., 1996).
Quantitation of Parasite Tissue Loads
Human fibroblast (Hs27; ATCC no. CRL-1634) cultures were used for parasite
burden quantification as previously described (Pfefferkorn and Pfefferkorn,
1976; Roos et al., 1994). Tissue single-cell suspensions (104 to 106 cells)
were added to the fibroblast monolayer cultures and titrated by plaque forma-
tion. The results of these titrations are reported in Plaque FormingUnits (PFUs).
In Vitro Assessment of Tachyzoite Killing
Macrophages harvested from naive mice by injecting cold RPMI into the peri-
toneal cavity were plated in flat-bottomed 96-well plates (3 3 105 per well) in
complete medium and incubated 2 hr at 37C. 53 104ME-49-RFP tachyzoites
were then added for 2 hr. After washing the infectedmonolayer, 105 CD4+GFP+
or GFP cells purified from Foxp3eGFP mice orally infected with ME-49 were
added in each well. Two days later, parasite growth was measured by fluores-
cence, and NO2
 levels were measured in culture supernatants by the Griess
assay as an indicator of reactive nitrogen intermediates.
Phenotypic Analysis
Cells from spleen, MLN, LP, and IEL were prepared as previously described
(Sun et al., 2007). Single-cell suspensions were incubated with anti-FcgIII/II
receptor antibody (93) and stained with fluorochrome-conjugated antibodies
against CD4 (RM4-5), CD8a (53-6.7), CD25 (PC61.5), CD62L (MEL-14),
TCR-b chain (H57-597), CD45.1 (A20), and CD45.2 (104) in PBS containing
or not containing 1% FBS for 20 min on ice and then washed. 7-amino-actino-
mycin D (7-AAD, eBioscience) or LIVE/DEAD Fixable Blue Dead cell stain kit
(Invitrogen) was used to exclude dead cells. For Foxp3 staining, cells were
subsequently stained using the Foxp3 staining set (eBioscience) according
to the manufacturer’s protocol. Nuclear Ki-67 and Bcl-2 staining were
performed using anti-Ki-67 (B56) and anti-Bcl-2 (3F11) from BD PharMingen.
For T-bet staining, anti-mouse/human T-bet (eBio4B10) from eBioscience
was used. Cell acquisition was performed on an LSRII machine using
FACSDiVa software (BD Biosciences). For each sample, at least 300,000
events were collected. Data were analyzed using FlowJo software (TreeStar).
In Vitro Restimulation and Intracellular Cytokine Detection
RPMI 1640 supplemented with 10%FBS, penicillin, streptomycin, gentamicin,
HEPES, glutamine, nonessential amino acids, and 50 mM of b-mercaptoetha-
nol was used for in vitro restimulation. For basal cytokine detection, spleen,Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc. 783
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cells/ml in a 96-well U-bottom plate and stimulated with 50 ng/ml PMA (Sigma)
and 5 mg/ml ionomycin (Sigma) in the presence of brefeldin A (GolgiPlug, BD
Biosciences). After 4 hr, samples were stained for dead cells as described
previously, washed twice with PBS, and fixed using 2% paraformaldehyde
(Electron Microscopy Sciences) solution. Cells were then stained with fluoro-
chrome-conjugated antibodies against TCR-b chain (H57-597), CD4 (RM4-
5), CD8a (53-6.7), IFN-g (XMG1.2), IL-10 (JES5-16E3), IL-2 (JES6-1A12),
Foxp3 (FJK-16 s), T-bet (eBio4B10), or isotype controls: rat IgG1 (eBRG1),
rat IgG2a (eBR2a), rat IgG2b (eB149/10H5), and mouse IgG1 (clone P3) in
the presence of anti-FcgIII/II receptor for 60 min in FACS buffer containing
0.6% saponin. All antibodies were purchased from eBioscience or BD Biosci-
ences. In some experiments, 2.53 105 LP TCR-b+CD4+ cells from naive or day
9 mice were incubated with 53 104 cells MACS-sorted splenic dendritic cells
in complete medium in a round-bottom 96-well plate in presence of STAg (5
mg/ml) for 15 hr. Brefeldin A was added for the last 6 hr, and cells were stained
for TCR-b, CD4, Foxp3, and IFN-g as previously described.
Lamina Propria DCs Purification
Lamina propria DCs (LpDCs) were purified from naive or T. gondii infected
small intestine. After LP digests were passed through 70 and 40 mm cell
strainers, cells were resuspended in 1.077 g/cm3 iso-osmotic NycoPrep
medium (Accurate Chemical & Scientific Corp.) and overlayed with RPMI
1640. The low-density fraction was collected after centrifugation at 1650 g
for 15min. Cells were washed and incubated with a mixture of mAb containing
anti-FcgIII/II receptor, 7-AAD viability staining solution, a-CD11c (HL-3),
a-MHCII (AF6-120.1), as well as the non-DC components a-DX5 (DX5),
a-NK1.1 (PK136), and a-B220 (RA3-6B2) (all from eBioscience). DCs were
defined as CD11c+MHCII+ cells, and non-DCs were excluded when sorted
by flow cytometry on a FACSAria. CD11c+MHCII+ cells were >90% and
used for in vitro conversion assays or cocultured with purified Treg cells.
T Cell Purification
Single-cell suspensions of spleen and MLN extracted from naive or day 8
infected Foxp3eGFP, Tbx21/, and C57BL/6 WT mice were enriched for
CD4+ T cells by negative selection using an autoMACs (Miltenyi Biotec). The
enriched fraction was further labeled with fluorescent dye-conjugated mAb,
including CD4 (RM4-5), CD25 (7D4), CD44 (IM7), and CD45RB (16A) (all
from eBioscience), and sorted by flow cytometry on a FACSVantage or
FACSAria (BD Biosciences). Purified CD4+CD25CD44loeGFP T cells
(<0.5% Foxp3+) were used for in vitro conversion assays. Purified CD4+eGFP+
or CD4+CD25+CD45RBlo were used for Treg cell-DC incubation. In prolifera-
tion assays, purified CD4+eGFP T cells and CD4+eGFP+ T cells were used.
In Vitro Conversion Assay
Conversion protocol was performed as previously described (Bettelli et al.,
2006), with T cells and LpDCs obtained as described above. LpDCs were puri-
fied from naive or day 6 infectedmice. In brief, FACS purified LpDCs and CD4+
T cells were cocultured at a 1:10 ratio (1 3 105 CD4+ T cells) in complete
medium (RPMI-1640 containing 10% FBS, 50 mM of b-mercaptoethanol,
and antibiotics) and Treg cell polarizing conditions (soluble a-CD3 mAb
[1 mg/ml] [BD Bioscience] and human rTGF-b [0.6 ng/ml] [R&D]). 5 ng/ml of
IL-2 was supplemented in cocultures every 2 days. STAg (5 mg/ml) and various
combinations of cytokines (10 ng/ml; IL-12, IFN-g fromR&D) ormAb (10 mg/ml;
a-IL12/23p40 [C17.8], a-IFN-g [XMG1.2 or 11B11] or isotype controls a-IgG2a
[R35-95], a-IgG1k [R3-34] from BD Biosciences) were added at the start of
cocultures in Treg cell polarizing conditions. On day 5, cells were stained
with the viabilitymarker 7-AAD (eBioscience) orwith LIVE/DEADkit (Invitrogen),
aCD4, aCD25, a-Foxp3, and/or a-T-bet and analyzed on an LSRII.
Suppression Assay
CD4+eGFP T cells were labeled with 1.25 mM CFSE (Invitrogen) in HBSS
(Mediatech Inc.) for 15 min at 37C. Cells were washed twice in media contain-
ing 10%FBS. 53 104CFSE-labeled CD4+eGFP T cells were cultured per well
of a 96-well U-bottom plate with 0.5 mg/ml of a-CD3 mAb (BD Bioscience) and
in presence of 105 irradiated T-depleted spleen cell feeders and decreasing
amounts of CD4+eGFP+ cells (at indicated ratio) during 3 days.784 Immunity 31, 772–786, November 20, 2009 ª2009 Elsevier Inc.Treg Cell Stimulation by DCs
5x104 CD4+CD25+CD45RBlo or CD4+eGFP+ T cells were cocultured in each
well with LpDCs purified from naive or day 6 infected mice (ratio 1:1) in
complete medium with soluble a-CD3 mAb (1 mg/ml) (BD Bioscience) and
5 ng/ml of IL-2. STAg (5 mg/ml) and various combinations of cytokines
or mAb, including IL-12, IFN-g, a-IL12/23p40, a-IFN-g, or isotype controls
were added at the start of coculture as described above. After a 5 day culture
at 37C, 5%CO2, Foxp3, T-bet, and cytokine staining was performed as previ-
ously described.
Oral Antigen Administration
Mice were infected orally or not with 40 ME49 cysts. Foxp3 T lymphocytes
from the secondary lymph nodes and spleen of OT-IIxFoxp3eGFP mice
(CD45.2) were purified by cell sorting, stained with CFSE, and adoptively trans-
ferred into naive or infected (day 4 postinfection) B6.SJL recipient mice
(CD45.1). Each mouse received 1.5 3 106 cells and then 1.5% OVA solution
dissolved in drinking water (grade V; Sigma-Aldrich) for 5 consecutive days.
On day 9, MLN and LP were collected from B6.SJL hosts, and Foxp3 expres-
sion was assessed in transferred cells. LN and LP single-cell suspensions
were prepared as described above.
Pathology Assessment
Mice were euthanized 9 or 10 days post-oral infection with 40 cysts of ME-49.
Their small intestines were removed and immediately fixed in a solution con-
taining 10% formalin. Paraffin embedded sections were cut at 0.5 mm and
stained with hematoxylin and eosin. The entire length of the small intestine
(duodenum, jejunum, ileum, and Peyer’s patch) was examined histologically.
Inflammation was scored on the following modified scale (Asseman et al.,
1999) of 0–5: 0, within normal limits; 1, minimal inflammatory leukocyte infil-
trates multifocally or locally; 2, mild inflammatory leukocytic and granulocytic
infiltrates within the lamina propria; 3, mild to moderate inflammatory infiltrates
in the lamina propria and submucosa, alterations in intestinal crypts, local to
diffuse thickening of themucosal epithelium; 4,moderate tomarked inflamma-
tory infiltrates of primarily viable and degenerate neutrophils, eosinophils,
lymphocytes, plasma cells admixed with cellular debris within the lamina prop-
ria, and submucosa with separation or loss of crypts; 5, marked to severe
inflammation diffusely with altered or complete loss of normal histologic struc-
tures and abundant inflammatory infiltrates that may extend transmurally (with
peritonitis). Sections of livers were evaluated for the numbers of inflammatory
loci and necrosis. Liver alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) levels were measured in serum samples, using commercially
available kits (Boehringer Mannheim).
Treatment with IL-2-Anti-IL-2 Complexes
Mice were inoculated orally with ME49 cysts, and IL-2 + aIL2 complexes were
administered or not administered intraperitoneally for 5 consecutive days. The
complex was formed by incubating 1.5 mg recombinant mouse IL-2 and 15 mg
of Functional Grade Purified anti-mouse IL-2 (Clone: JES6-1A12, eBioscience)
for 5 min at room temperature.
Quantitative RT-PCR
Splenic and LP total cells or DCs were purified from mice at 6 or 9 days
postinfection. RNA were then extracted with RNAeasy columns (QIAGEN)
and analyzed by quantitative RT-PCR according to themanufacturer’s instruc-
tions using primers for murine IL-2, IL-12p40, IL-12p35, EBI3, and IL-27p28
(QIAGEN).
pSTAT-4 Detection
5 3 105 MLN cells from ME-49 infected mice were stimulated in vitro with
10 ng/ml of recombinant mouse IL-12 (R&D) during 20 min. Cells were then
fixed for 20 min using 2% paraformaldehyde solution, permeabilized with
90%methanol solution for 30 min, and stained in PBS with antibodies against
TCR-b, CD4, Foxp3, and pSTAT-4 (38/p-Stat4, BD Bioscience) or mouse
a-IgG2bk isotype control.
Confocal Analysis
Small intestines for confocal imaging were processed by the ‘‘swiss roll’’
method. Briefly, the small intestines were removed, cut open longitudinally,
Immunity
Treg Collapse during Infectionandwashed in PBS. They were then sectioned into three pieces of equal length
and rolled around a small wooden dowel with the villi facing outward. After fixa-
tion overnight in 4% formaldehyde, the intestines were dehydrated in 30%
sucrose for at least 24 hr. The rolls were then frozen in Tissue FreezingMedium
(Electron Microscopy Sciences) and sectioned at 15 mm. Sections were
mounted on Superfrost Plus slides (Electron Microscopy Sciences) and
stained with CD4 Alexa Fluor 700 (eBioscience) and Hoechst 33342 (Invitro-
gen) followed by mounting with Prolong Gold (Invitrogen). Images were taken
on a Leica SP5 microscope, and image processing was performed using
Imaris software (Bitplane).
Statistical Analysis
Groups were compared with Prism software (GraphPad) using the unpaired or
paired Student’s t test.
SUPPLEMENTAL DATA
The Supplemental Data include eight figures and can be found with this article
online at http://www.cell.com/immunity/supplemental/S1074-7613(09)00454-3.
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